ESC Premium Access

Combined pre- and post-capillary pulmonary hypertension defined by new criteria is worse prognosis group in patients with heart failure

Congress Presentation

About the speaker

Doctor Tatsuro Ibe

Jichi Medical University Saitama Medical Center, Saitama (Japan)
0 follower

5 more presentations in this session

Prognostic implication of sodium nitroprusside vasodilator test in pulmonary hypertension and left heart disease: insights from PUSHON registry.

Speaker: Doctor P. Boretto (Turin, IT)


Prognostic role of comorbidities in patients with pulmonary arterial hypertension

Speaker: Doctor A. De Lorenzis (Bologna, IT)


Clinical characteristics and prognostic impact of pulmonary hypertension in heart failure with preserved ejection fraction: the PURSUIT HFpEF study

Speaker: Doctor F. Sera (Suita, JP)


The association between atrial fibrillation and pulmonary embolism

Speaker: Doctor E. Svennberg (Stockholm, SE)


Modeling survival using decision tree analysis in pulmonary hypertension due to left heart disease. the prognostic significance of PVR < 3WU when TAPSE < 16mm

Speaker: Mr C. Fauvel (Rouen, FR)


Access the full session

The Conundrum of Pulmonary Hypertension due to Left Heart Disease – Can Science Help?

Speakers: Doctor T. Ibe, Doctor P. Boretto, Doctor A. De Lorenzis, Doctor F. Sera, Doctor E. Svennberg...

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb